期刊文献+

节拍化疗在乳腺癌治疗中的应用 被引量:4

The application of metronomic chemotherapy in the treatment of breast cancerThe application of metronomic chemotherapy in the treatment of breast cancer
下载PDF
导出
摘要 节拍化疗是近年来兴起的一种全新的化疗模式,是利用低剂量、多次不间断给药的方式,通过持续抑制肿瘤新生血管生成,达到缩小肿瘤体积、控制肿瘤生长、减少相关药物的不良反应、提高相关疗效、减少相关药物耐药性的作用。目前,在转移性乳腺癌患者的临床治疗中已经取得了肯定的治疗效果。随着治疗模式的改变、概念的不断更新以及越来越多的相关治疗机制被发现,目前节拍式治疗已经不仅是节拍化疗,而是贯穿化疗、放疗、内分泌治疗及相关辅助治疗的治疗模式。本文就节拍化疗在乳腺癌治疗中的应用作一综述。 Metronomic chemotherapy is a very new form of chemotherapy that has been rising in popularity in recent years. In low-dosages with continuous administration, it could sustainably inhibits tumor angiogenesis, reduces tumor size, controls tumor growth, reduces toxicity and side-effects, improves efficacy and reduces drug resistance. In the clinical treatment of patients with metastatic breast cancer, it has had positive treatment responses. With changes in treatment patterns and constant updates, more relevant therapeutic mechanisms were found, metronomic therapy was no longer used in encompassing just metronomic chemotherapy, but also chemotherapy, radiotherapy, adjuvant endocrine therapy and related treatment modalities. This interview was aimed to summarized the application of metronomic chemotherapy in the treatment of breast cancer.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2012年第3期223-226,共4页 China Oncology
关键词 节拍化疗 乳腺癌 靶向治疗 放射治疗 新辅助治疗 血管生成抑制剂 Metronomic chemotherapy Breast cancer Molecular targeted therapy Radiotherapy Neoadjuvant therapy Angiogenesis inhibitors
  • 相关文献

参考文献33

  • 1FOLKMAN J. Tumor angiogenesis: therapeutic implications [J]. N Engl J Med, 1971, 285(21): 1182-1186.
  • 2BROWDER T, BUTTERFIELD C E, KRALING B M, et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer [J]. Cancer Res, 2000, 60(7): 1878-1886.
  • 3HANAHAN D, BERGERS G, BERGSLAND E. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice [ J ] . J Clin Invest, 2000, 105(8): 1045-1047.
  • 4EMMENEGGER U, MORTON G C, FRANCIA G, et al. Low-dose metronomic daily cyclophosphamide and weekly timpazamine: a well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia [ J 1 ~ Cancer Res, 2006, 66(3): 1664-1674.
  • 5COLLEONI M, ROCCA A, SANDRI M T, et al. Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer:antitumor activity and correlation with vascular endothelial growth factor levels [J]. Ann Oncol, 2002, 13(1):73-80.
  • 6GIOVANNINI M, ALDRIGHETTI D, ZUCCINELLI P, et al. Antiangiogenic strategies in breast cancer management [J]. Crit Rev Oncol Hematol, 2010, 76(1): 13-35.
  • 7杨芳,张清媛,康欣梅.希罗达对4T1乳腺癌小鼠肿瘤血管生成的影响[J].现代生物医学进展,2007,7(9):1294-1296. 被引量:13
  • 8VACCA A, IURLARO M, RIBATTI D, et al. An- tiangiogenesis is produced by nontoxic doses of vinblastine [J].Blood, 94: 4143-4155.
  • 9HIRAGA T, HATA K, IKEDA F, et al. Preferential inhibition of bone metastases by 5' -deoxy-5-fluorouridine and capecitabine in the 4T1/luc mouse breast cancer model [ J ] . Oncel Rep, 2005, 14(3): 695-699.
  • 10TODOROVA V K, KAUFMANN Y, KLIMBERG V S. Increased efficacy and reduced cardiotoxicity of metronomic treatment with cyclophosphamide in rat breast cancer [J]. Anticancer Res, 2011, 31(1): 215-220.

二级参考文献16

共引文献18

同被引文献11

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部